The Trump administration has made very clear they support growing LNG exports,” Venture CEO Mike Sable told CNBC in an ...

Shares of Ascentage Pharma Group International rose as much as 4% in the Chinese biopharmaceutical company’s US trading debut ...

The U.S. IPO market is expected to see a blowout 2025, fueled by the return of business-friendly Donald Trump to the White ...

When Donald Trump’s real estate business wanted to break into the Indian market in 2012, it turned to Atul Chordia and his ...

Liquefied natural gas exporter Venture Global said on Thursday it had raised $1.75 billion, marking the first big initial ...

Venture Global LNG has raised $1.75 billion after pricing its U.S. initial public offering within range, the second-largest ...

The year 2025 is expected to see a resurgence of IPOs due to policy changes, monetary easing, and a favorable business ...

After what many considered a “slow” year for IPOs, January has ushered in a string of biotechs filing to go public. But 2024 ...

Energy company Venture Global prices 70 million shares at $25 — the middle of its reduced $23-$27 price range.

The San Diego–based company’s molecules avoid the well-trod GLP-1 pathway in favor of an alternate route in the gut.

Capillary Technologies has restarted the preparations for its IPO and is likely to file the IPO papers for a $200 Mn public ...